CoChat

Dopamine Agonist Increases Risk Taking but Blunts Reward-Related Brain Activity

Open access
Riba, Jordi, Krämer, Ulrike M., Heldmann, Marcus, Richter, Sylvia, Münte, Thomas F. · 2008 · PLoS ONE
Cited by 151

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

The use of D2/D3 dopaminergic agonists in Parkinson's disease (PD) may lead to pathological gambling. In a placebo-controlled double-blind study in healthy volunteers, we observed riskier choices in a lottery task after administration of the D3 receptor-preferring agonist pramipexole thus mimicking risk-taking behavior in PD. Moreover, we demonstrate decreased activation in the rostral basal ganglia and midbrain, key structures of the reward system, following unexpected high gains and therefore propose that pathological gambling in PD results from the need to seek higher rewards to overcome the blunted response in this system.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0002479

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 151

Metadata

Authors
Riba, J., Krämer, U. M., Heldmann, M., Richter, S., & Münte, T. F.
Venue
PLoS ONE
Published
2008-06-25
Volume
3
Issue
6
Pages
e2479
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2024770568
Cited by
151
References
8
FWCI
5.70
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dopamine Agonist Increases Risk Taking but Blunts Reward-Related Brain Activity. https://app.cochat.ai/papers/10.1371/journal.pone.0002479
The paper
Riba, J., Krämer, U. M., Heldmann, M., Richter, S., & Münte, T. F. (2008). Dopamine Agonist Increases Risk Taking but Blunts Reward-Related Brain Activity. PLoS ONE. https://doi.org/10.1371/journal.pone.0002479

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.